Skip to content
Screener
Evommune logo

Evommune

EVMN

Evommune is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Luis C. Pena, with a market cap of $277.6M.

Market cap
$277.63M-52.7%

We’re still putting together Evommune’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Evommune up the queue, and we’ll analyze its filings next.

Earnings

Q3 2026 report

November 12, 2026

Next report

Date not yet announced

Profile

Listed2025
Employees48.0
CEOLuis C. Pena
FilingsSEC EDGAR